Creatinine level 2.5 mg/dL
Creatine is a nitrogenous organic acid that occurs naturally in vertebrates and helps to supply energy to all cells in the body, primarily muscle. Creatine is naturally produced in the human body from amino acids primarily in the kidney and liver. It is transported in the blood for use by muscles. Approximately 95% of the human body's total creatine is located in skeletal muscle. after metabolism, creatinine will come to kidney for filtration. When the kidney is damaged, the ability of discharging creatinine will also decrease.
What is the normal range of creatinine (High Creatinine Levels )? Different labs have different standards. Generally, the normal range is 0.53 to 1.1. What does creatinine level 2.5 mean? Firstly, we should explain the specific ones according to the different stages.
Stage 1 GFR ≥90 mL/min/1.73m2 creatinine normal
Stage 2 GFR 60-89 mL/min/1.73m2 creatinine 133-177μmol/L (1.6-2.0mg/dL)
Stage 3 GFR 30-59 mL/min/1.73m2 creatinine 186-142μmol/L (2.1-5.0mg/dL)
Stage 4 GFR 15-29 mL/min/1.73m2 creatinine 451-707μmol/L (5.1-7.9mg/dL)
Stage 5 GFR <15 mL/min/1.73m2 creatinine 451-707μmol/L (5.1-7.9mg/dL)
From the above, we can find out that creatinine 2.5 mean that patients have come into stage 3 of chronic kidney disease. In this stage, chronic kidney disease patients may have the following symptoms such as fatigue, too much fluid in the body or edema, back in pain, sleeping problem, hematuria(Hematuria and Kidney Disease), proteinuria (Proteinuria and Kidney Disease), and so on.
What should chronic kidney disease patients do to prevent from such high creatinine?
In western countries, hormones and immunosuppressive agent is applied. After applying for a long time, chronic kidney disease patients will find out that they can only stop the symptoms for the time being and can not treat chronic kidney disease from root. In the research of the kidney disease causes, we find out that most or 95% of kidney disease is caused by the disorder of immune Immunotherapy. So we created a new immunotherapy.